Karuna Therapeutics, Inc.

KRTX · NASDAQ
Analyze with AI
12/31/2023
9/30/2023
6/30/2023
3/31/2023
Assets
Cash & Equivalents$185,823$184,471$263,603$562,660
Short-Term Investments$1,076,990$1,157,039$1,172,907$909,761
Receivables$4,900$4,900$0$0
Inventory$32,831$7,495$0$0
Other Curr. Assets$14,769$11,492$6,693$35,338
Total Curr. Assets$1,315,313$1,365,397$1,451,947$1,507,759
Property Plant & Equip (Net)$20,514$19,318$19,617$7,930
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0-$2,033-$2,033$0
Tax Assets$0$0$0$0
Other NC Assets$382$2,415$2,572$479
Total NC Assets$20,896$19,700$20,156$8,409
Other Assets$0$0$0$0
Total Assets$1,336,209$1,385,097$1,472,103$1,516,168
Liabilities
Payables$6,783$2,939$1,102$476
Short-Term Debt$2,843$1,796$1,977$2,067
Tax Payable$0$0$0$0
Deferred Revenue$41,609$44,129$0$0
Other Curr. Liab.$16,894$104$35,524$22,694
Total Curr. Liab.$68,129$48,968$38,603$25,237
LT Debt$13,845$13,813$13,833$2,692
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$104$104
Total NC Liab.$13,845$13,813$13,937$2,796
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$81,974$62,781$52,540$28,033
Equity
Pref Stock$0$0$0$0
Common Stock$4$4$4$4
Retained Earnings-$997,887-$884,063-$764,944-$661,781
AOCI$211-$2,929-$3,642-$1,615
Other Equity$2,251,907$2,209,304$2,188,145$2,151,527
Total Equity$1,254,235$1,322,316$1,419,563$1,488,135
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,336,209$1,385,097$1,472,103$1,516,168
Net Debt-$169,135-$168,862-$247,793-$557,901